CorMedix Inc (CRMD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $370.64M
Last updated: Nov 17, 2026 at 4:18 PM ET
CorMedix Inc (CRMD) Stock Chart
CorMedix (CRMD) has a latest price of $4.67 on Nov 17, 2026, 64.1% below its 52-week high of $13.02. Its price fell 58.5% over the past 12 months. The month-end price fell 45.5% over the 10 years through Oct 2026, a compound annual decline of 5.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $15.00 in Feb 2021 and its lowest $0.90 in Mar 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CRMD with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRMD.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 45.2%, and over 6 months it fell 40.3%. The month-end price rose 63.6% over the 3 years through Oct 2026, a compound annual rate of 17.8%.
| Period | Change |
|---|---|
| 1 month | -36.7% |
| 3 months | -45.2% |
| 6 months | -40.3% |
| 12 months | -58.5% |
| 12 months, with dividends | -58.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +63.6% | +17.8% |
| 5 years | +17.2% | +3.2% |
| 10 years | -45.5% | -5.9% |
Price by Year
Its best calendar year was 2018, when the price rose 158.0%, and its weakest was 2017, when it fell 67.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $5.70 | -51.0% |
| 2025 | $11.63 | +43.6% |
| 2024 | $8.10 | +115.4% |
| 2023 | $3.76 | -10.9% |
| 2022 | $4.22 | -7.3% |
| 2021 | $4.55 | -38.8% |
| 2020 | $7.43 | +2.1% |
| 2019 | $7.28 | +12.9% |
| 2018 | $6.45 | +158.0% |
| 2017 | $2.50 | -67.3% |
Trading Range
The price is 33.6% below its 50-day average of $7.04 and 38.0% below its 200-day average of $7.53.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.67 | |
| 52-week high | $13.02 | -64.1% |
| 52-week low | $4.65 | +0.4% |
| 50-day average | $7.04 | -33.6% |
| 200-day average | $7.53 | -38.0% |
Price Risk
Over 3 years, its largest fall from a peak was 71.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.34 |
| Largest fall, 1 year | -63.4% |
| Largest fall, 3 years | -71.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CRMD
What is CRMD's 1-year price change?
CorMedix's price fell 58.5% over the past 12 months. With dividends included, the 12-month total return was -58.5%.
What is CRMD's 5-year price change?
CorMedix's month-end price rose 17.2% over the 5 years through Oct 2026, a compound annual rate of 3.2%. These figures leave out dividends.
What is CRMD's 52-week high and low?
CorMedix's 52-week high is $13.02 and its 52-week low is $4.65. Its latest price of $4.67 on Nov 17, 2026 is 64.1% below the high.
What is CRMD's beta?
CorMedix's 1-year beta against the S&P 500 is 1.34, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 63.4%.
Is the CRMD chart free?
Yes. Advanced Charting for CRMD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CRMD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors